LED Medical Diagnostics Inc. (“LED Medical” or “the Company”), has announced the results of an oral health screening program in conjunction with London Drugs, a Canada-based pharmacy and retailer with 78 stores across British Columbia, Alberta, Saskatchewan and Manitoba. Following a successful pilot oral mucosal screening program in 2015, London Drugs again offered customers the opportunity to have a comprehensive oral examination to screen for oral mucosal abnormalities while incorporating tissue fluorescence visualization technology.
The screenings incorporate the use of LED Medical Diagnostics’ VELscope® Vx Enhanced Oral Assessment System, a device utilized as an adjunct to the comprehensive oral examination, that enhances the ability of clinicians to visualize oral mucosal abnormalities that many not be apparent to the naked eye, including oral cancer, pre-malignant dysplasia and infections. The oral health screenings were conducted by Stacey-Rhodes Nessett, a Registered Dental Hygienist, and Dr. Ken Neuman, an accomplished dentist and member of the University of British Columbia Faculty of Dentistry.
To view the full story, please visit: http://www.stockhouse.com/news/press-releases/2016/08/11/led-medical-diagnostics-announces-successful-oral-health-screening-program
